Medial Research is a pioneer in the field of algorithmic analysis of medical data. Using advanced, proprietary technology, Medial analyzes large patient databases and develops products based on multidimensional predictive models that accurately evaluate personal risk levels and support the medical community in the diagnostic and therapeutic decision-making process. The company's first product, MeScore CRC, offers population-based eScreening for colorectal cancer in a simple, cost-effective program that has the potential to significantly improve compliance.

Entegrion is a life sciences company dedicated to providing innovative solutions. Their products bring about major changes to the critical pathways in the diagnosis and treatment of patient coagulopathies, enabling clinicians to rapidly and effectively advance care in both the hospital and field environments. They partner with leading scientists, clinicians, and industry specialists to provide products that enable doctors to improve clinical outcomes for patients whose hemostatic state may be compromised.

Biotherapy Services is a specialist pharmaceutical biotech company. We use state-of-the-art technology and patented proprietary processes, working to GMP (Good Manufacturing Practice) pharmaceutical manufacturing standards, to produce a range of clinically safe and effective autologous biotherapies for a broad range of clinical conditions.

Cellphire has developed a proprietary method for the stabilization of blood in the dry state Current efforts and product development are aimed toward stabilized platelets for advanced wound care, transfusion, and reagent products for clinical and research diagnostics. We have been able to stabilize and modify platelets into a hemostatic agent that can be stored well beyond the current limit of 5 days. Platelets cannot be stockpiled and shortages occur because of this extremely short shelf life. These shortages can interrupt the treatment of cancer patients and actively bleeding surgical or trauma patients. The fragility of the national supply of platelets is a topic of discussion of several task forces and agencies planning the nation's response to a pandemic such as avian influenza. This and other natural or manmade disasters would interrupt or exceed the available supply of platelets that is needed to maintain an adequate supply or treat bleeding casualties.

Kangkne Biomedical (Shenzhen) Co., Ltd., established on 2016-08-24, Business scope includes general business items:Import and export of goods or technology;e-commerce;Chemical Products,Polymer Materials,R&D and sales of fiber materials and related equipment;Technical development of protective materials;coating,Sales of fireproof materials;Sales of Class I medical supplies and equipment;Information Consulting(No restricted items);Agricultural Technology,Biotechnology,new material technology,Promotion of Energy Saving Technology;Technical development of biological products;Technology development of biotechnology products;Domestic Trade(Does not contain franchise,monopoly,Specially Controlled Commodities),The licensing program is:Class III medical device business.

Pplus Skin Care Limited is a UK-registered company founded in 2014 by Dr Mitra Najafi (MD), a multi award winning cosmetic clinician who has spent several years on R&D and developed the first prototype of Pplus products which provide pain free, none-invasive and more affordable application of PRP. An innovative product tailor made and unique for every individual.

Peking University Third Hospital is a private company headquartered in Beijing, China, that operates as a clinic.

Forever Labs collects and stores adult stem cells, and develops therapies based upon stem cell rejuvenation.

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, Hospital, and Corporate. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.

CellSource Co., Ltd. engages in regenerative medicine related business. Its business includes fat, blood-derived tissue and cell processing service. It also offers regenerative medicine legal support service, sale of medical device, cosmetics and facial products. It operates through the Regenerative Medicine-related and Consumer business segments. The Regenerative Medicine-related segment handles stem cell processing contract service, blood derived processing contract service and consulting service. It also sells equipment necessary for medical institutions to collect fat from patients. The Consumer segment mainly manufactures and sells cosmetics for the general consumer, such as beauty liquids, creams, facial cleansing gels, and own cosmetic brand SIGNALIFT. The company was founded on November 30, 2015 and is headquartered in Tokyo, Japan.

Guangdong Handing Medical Technology Co., Ltd., established on 2021-10-28, Business scope includes technical services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Production of Class II Medical Devices;Production of Class III Medical Devices;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Class III medical device business;Production of hygiene products and single-use medical products;pharmaceutical production;Drug Wholesale;Drug import and export;Pharmaceutical commissioned production;Domestic trade agent;Health Consulting Services(Does not include medical services);Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval);Information Consulting Service(Not including licensing information consulting services);marketing planning;Conference and Exhibition Services;software development;Engage in investment activities with own funds.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Henan Huibo Medical Co., Ltd., established on 2004-11-10, Business scope includes general items:Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Disinfectant sales(Free of Hazardous Chemicals);Cosmetics Wholesale;Sales of hygiene products and single-use medical products;Production of special labor protection products;Sales of special labor protection products;daily mask(non-medical)Production;daily mask(non-medical)Sales;Mechanical Parts,Parts processing;Mechanical Parts,Parts sales;Manufacture of technical textile products;Sales of knitted textiles and raw materials;software development;software sales;Retailing of computer software, hardware and auxiliary equipment;Computer System Services;Manufacturing of computer software, hardware and peripheral equipment;Import and export;Technology Import and Export;Class I Medical Device Leasing;Class II Medical Device Leasing;Sales of formula food for special medical purposes;Non-residential real estate leases;property management;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Manufacturing of daily chemical products;Sales of daily chemical products;Daily necessities sales;Sports goods and equipment manufacturing;Personal Hygiene Sales;Machinery sales;Machinery and Equipment Leasing;Mechanical equipment research and development;Sales of plastic products;Synthetic Materials Sales;Auto New Car Sales;car used car sales;Artificial intelligence application software development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Production of sterile equipment;Disinfection equipment sales;Disinfectant production(Free of Hazardous Chemicals);Cosmetic production;Production of hygiene products and single-use medical products;Class III Medical Device Leasing;food sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Shandong Zhongbaokang Medical Equipment Co., Ltd., established on 1996-11-15, Business scope includes general items:Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Non-residential real estate leases;Special Equipment Repair(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;pharmaceutical production;Drug Wholesale;Drug retail;Import and export(Except for projects subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Guangdong Xiankangda Biotechnology Co., Ltd., established on 2019-01-16, Business scope includes technology development and technology transfer of biotechnology products;Health Consulting Services;Cell Immunotherapy Stem Cell Therapy Technology,gene editing technology,Research and development of biologics technology;cell medicine research,technical consulting;cell storage;R&D and sales of Class I medical devices,Class II medical device,Research and Development of Class III Medical Devices;cosmetic,skin care products,R & D and sales of health care products;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guangzhou Zhunyou Biotechnology Co., Ltd., established on 2015-09-25, Business scope includes research in health science projects,to develop;Research and development of biological products(Does not include licensed operations);Medical Research and Experimental Development;Biotechnology Development Services;Biotechnology Consulting,communication service;Biotechnology Transfer Services;Disinfection supplies sales(Except for projects involving licensing);Retailing of cosmetics and hygiene products;Medical supplies and equipment retail(Does not contain drugs and medical devices);Commodity retail trade(Except for licensed and approved products);Medical technology promotion service;Medical Technology Consulting,communication service;Medical technology transfer service;Regenerative Medicine Anti-aging Research Services;Biomedical Technology Research;Medical technology research and development;Stem Cell Technology Research,to develop;Stem Cell Biotechnology Consulting Services;Stem Cell Biotechnology Transfer Services;Stem Cell Biotechnology Services;medical diagnosis,Monitoring and treatment equipment retail;collection of stem cells,storage,preparation service(Without umbilical cord blood hematopoietic stem cell collection,storage);Collection of immune cells,storage,preparation service(Without umbilical cord blood hematopoietic stem cell collection,storage);medical management;Genetic testing and disease screening services;

Biosafe SA operates as a medical technology company. It provides automated adult stem cell processing services. The firm specializes in the field of adult stem cell therapy, serving stem cell banks, hospitals and research institutes. The company was founded by Claude Fell and Lia Fell-Zakrajsek in 1997 and is headquartered in Eysins, Switzerland.

Zhejiang Baoman Biotechnology Co., Ltd., established on 2013-11-29, Business scope includes licensed projects:Production of Class III Medical Devices;Production of Class II Medical Devices;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Production of Class I Medical Devices;Sales of Class II Medical Devices;Sales of Class I Medical Devices;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Import and export(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).